Related Experiment Video
Updated: Jun 17, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Molecular basis of hereditary cardiomyopathy: abnormalities in calcium sensitivity, stretch response, stress response
1Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University, Japan. akitis@mri.tmd.ac.jp
Insights
Genetic mutations in cardiomyopathy can cause different clinical types, affecting cardiac muscle function. Understanding these genetic links offers new therapeutic strategies for hereditary heart muscle diseases.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Cardiomyopathy stems from cardiac muscle functional abnormalities, with intrinsic factors causing primary or idiopathic forms.
- Primary cardiomyopathies include hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).
- Hereditary primary cardiomyopathy research has identified disease genes through linkage studies and candidate gene approaches.
Purpose of the Study:
- To explore the genetic etiology and functional alterations in hereditary primary cardiomyopathies.
- To investigate the relationship between specific gene mutations and different clinical cardiomyopathy types.
- To identify potential therapeutic targets based on elucidated genetic and functional mechanisms.
Main Methods:
- Linkage studies and candidate gene approaches to identify disease genes.
- Functional analyses of disease-related mutations.
- Investigating mutations in sarcomere, Z-disc, and I-region components.
Main Results:
- Mutations in the same gene can manifest as different cardiomyopathy types (HCM, DCM).
- Sarcomere mutations are linked to altered Ca(2+) sensitivity (increased in HCM, decreased in DCM).
- Z-disc and I-region mutations are associated with altered sarcomere stiffness and stress response, respectively.
Conclusions:
- Elucidating genetic causes and functional impacts of mutations provides insights into cardiomyopathy pathogenesis.
- Understanding these mechanisms opens avenues for novel therapeutic strategies for hereditary cardiomyopathies.
- Targeting specific functional alterations, like Ca(2+) sensitivity in DCM, shows promise in preclinical models.
Abstract:
Cardiomyopathy is caused by functional abnormality of cardiac muscle. The functional abnormality involved in its etiology includes both extrinsic and intrinsic factors, and cardiomyopathy caused by the intrinsic factors is called as idiopathic or primary cardiomyopathy. There are several clinical types of primary cardiomyopathy including hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Linkage studies and candidate gene approaches have explored the disease genes for hereditary primary cardiomyopathy. The most notable finding was that mutations in the same disease gene can be found in different clinical types of cardiomyopathy. Functional analyses of disease-related mutations have revealed that characteristic functional alterations are associated with the clinical types, such that increased and decreased Ca(2+) sensitivity due to sarcomere mutations are associated with HCM and DCM, respectively. In addition, our recent studies have suggested that mutations in the Z-disc components found in HCM and DCM may result in increased and decreased stiffness of sarcomere; that is, stiff sarcomere and loose sarcomere, respectively, and hence altered stretch response. More recently, mutations in the components of I region were found in hereditary cardiomyopathy and the functional analyses of the mutations suggested that the altered stress response was associated with cardiomyopathy, further complicating the etiology and pathogenesis. However, elucidation of genetic etiology and functional alterations caused by the mutations shed lights on the new therapeutic approaches to hereditary cardiomyopathy, such that treatment of DCM with a Ca(2+) sensitizer prevented the disease in a mouse model.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mechanism of Cardiac Arrhythmias
Cardiomyopathy V: Interprofessional Care

